(Q43955104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

The role of heparin in the management of consumption coagulopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

The Role of Heparin in the Management of Consumption Coagulopathy (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

28 March 2023

author name string

D. Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5007331

28 March 2023

R. A. Seeler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5007331

28 March 2023

N. Allen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5007331

28 March 2023

I. A. Alavi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5007331

28 March 2023

language of work or name

1 reference

1 January 1972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

11 September 2019

https://api.elsevier.com/content/article/PII:S0025712516324348?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

https://api.elsevier.com/content/article/PII:S0025712516324348?httpAccept=text/plain

28 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

Medical Clinics of North America

28 March 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

193-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

Acute toxoplasmosis complicating leukemia. Diagnosis by bone marrow aspiration

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Recognition and treatment of intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Sequential Coagulation Studies in Purpura Fulminans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Treatment of patients with microangiopathic haemolytic anaemia with heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1969

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Hypofibrinogenemia in scrub typhus. Report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Treatment of gram-negative shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Heparin therapy in septicemia with disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Changes in the blood coagulation system associated with septicemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

The role of the liver in serum-induced hypercoagulability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Disseminated intravascular coagulation associated with aspergillus endocarditis. Fatal outcome following heparin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Defibrination syndrome in an infant born after abruptio placentae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Fatal intravascular consumption coagulopathy in meningococcal sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Consumption Coagulopathy in Miliary Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

STUDIES ON BLOOD COAGULATION FACTORS IN A CASE OF LIVER CIRRHOSIS. REMISSION OF THE HEMORRHAGIC TENDENCY ON TREATMENT WITH HEPARIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

CLINICAL AND GENETIC ASPECTS OF COAGULOPATHIES WITH SPECIAL EMPHASIS ON GENERALIZED INTRAVASCULAR CLOTTING.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Pathophysiology, clinical manifestations and therapy of consumption-coagulopathy (“Verbrauchskoagulopathie”)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Purpura fulminans treated successfully with anticoagulation; report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Intravascular coagulation in fulminant meningococcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Therapeutic implications of disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Diagnosis and treatment of intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Chronic intravascular coagulation syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Heparin therapy in fulminant meningococcemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Defibrination syndrome in a patient with chronic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Dextran Therapy of Purpura Fulminans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Alterations in the blood clotting system in disseminated intravascular coagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Intravascular coagulation in acute hepatic necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Intravascular coagulation in a case of Clostridium perfringens septicaemia: treatment by exchange transfusion and heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

The haemorrhagic diathesis of heatstroke. A consumption coagulopathy successfully treated with heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932434-8

Effects of fibrinogen degradation products on platelets and coagulation

7 January 2021

24

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

Disseminated Intravascular Coagulation in a Neonate

28 March 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

Progress in disseminated intravascular coagulation

28 March 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

Fibrinolysis and thrombosis

28 March 2023

41

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

Acute and chronic "defibrination" in obstetrical practice

28 March 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32434-8

28 March 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5007331%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference